NCT07394816 Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?
| NCT ID | NCT07394816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
| Condition | Postoperative Pulmonary Complications (PPCs) |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-03-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to evaluate whether the use of ultrasound-guided fascial plane blocks is associated with a lower incidence of postoperative pulmonary complications in adult patients undergoing elective major abdominal surgery under general anesthesia. Patients will be observed in two groups based on routine clinical practice: those who receive an ultrasound-guided fascial plane block for postoperative analgesia and those managed with other standard analgesic methods. The choice of analgesic technique will be determined by the responsible anesthesia team and not influenced by the study. Postoperative pulmonary complications occurring within the first 7 days after surgery will be recorded using reopening the European Perioperative Clinical Outcome (EPCO) criteria. Secondary outcomes will include unplanned intensive care unit admission, length of hospital stay, and 30-day mortality. No additional procedures or interventions will be performed for research purposes.
Eligibility Criteria
Inclusion Criteria: * Age 65 years or older * Scheduled for elective major abdominal surgery (e.g., colorectal, hepatobiliary, pancreatic, or gastric surgery) * ASA physical status II-III * Ability to provide written informed consent * Planned use of general anesthesia with or without adjunct regional techniques Exclusion Criteria: * Refusal or inability to provide informed consent * Known allergy or contraindication to local anesthetics * Coagulopathy or ongoing anticoagulant therapy contraindicating regional anesthesia * Infection at the site of planned block * Pre-existing chronic opioid use or chronic pain syndrome * Severe hepatic, renal, or cardiac failure (e.g., Child-Pugh C, end-stage renal disease, EF \<30%) * Cognitive impairment or severe dementia preventing adequate pain assessment * Emergency surgery * Body mass index (BMI \> 40 kg/m²)
Contact & Investigator
arif timuroglu
PRINCIPAL INVESTIGATOR
Dr. Abdurrahman yurtaslan Ankara Oncology Hospital
Frequently Asked Questions
Who can join the NCT07394816 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Postoperative Pulmonary Complications (PPCs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07394816 currently recruiting?
Yes, NCT07394816 is actively recruiting participants. Contact the research team at ariftimuroglu@yahoo.com for enrollment information.
Where is the NCT07394816 trial being conducted?
This trial is being conducted at Yenimahalle, Turkey (Türkiye).
Who is sponsoring the NCT07394816 clinical trial?
NCT07394816 is sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The principal investigator is arif timuroglu at Dr. Abdurrahman yurtaslan Ankara Oncology Hospital. The trial plans to enroll 500 participants.